could join rival drugs from Sanofi/Regeneron and GlaxoSmithKline as approved therapies for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been shown to reduce symptoms. Sanofi ...
based on an analysis of (1) the occurrence of polyps and of allergy, (2) the anatomy and histology of nasal polyps, (3) the inflammation in nasal polyps, (4) the occurrence of positive allergy tests ...
Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have a high burden of systemic corticosteroid (SCS ... The primary outcomes were all-cause SCS use and CRSwNP-only SCS use, use of other ...
Dupixent belongs to a group of drugs called monoclonal antibodies ... Dupixent is used to treat chronic rhinosinusitis with nasal polyps in adults and children ages 12 years and older.
Dr Afzal Vattai Purath, an ENT specialist at Zulekha Hospital in Dubai, said treatment for rhinitis ... triggers and using saline nasal sprays can also help reduce secondary infections and clear ...
In the case of TMD, cold packs or heating pads may help reduce the pain. Jaw exercises have also been ... can help prevent nasal obstruction caused by allergies. In the case of nasal polyps or tumors, ...
Eardrum injuries, nasal polyps, or even teething in babies can cause fluid to build up in the ear. The blockage traps fluid in the middle ear in the space behind the eardrum, leading to symptoms like ...
A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the standard oral and intravenous formulations of the medication ...